Loading clinical trials...
Loading clinical trials...
This is a non-interventional, prospective, post authorization safety study. Patients with gMG who are expected to start treatment with efgartigimod at enrolment or are within their first cycle of efgartigimod at enrolment will be eligible to enroll into the efgartigimod cohort. Patients with gMG who have not been exposed to efgartigimod and for whom it is not planned to start treatment with efgartigimod at enrolment will be eligible to enroll into the non-efgartigimod cohort.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center,
San Francisco, California, United States
SFM Clinical Research, LLC
Boca Raton, Florida, United States
University of Florida College of Medicine Jacksonville
Jacksonville Beach, Florida, United States
Medsol Clinical Research Center Inc
Port Charlotte, Florida, United States
BayCare Health System, Inc. St Anthony's Hospital
St. Petersburg, Florida, United States
Prairie Education and Research Cooperative and HSHS Medical Group
O'Fallon, Illinois, United States
University of Iowa
Iowa City, Iowa, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Norton Neuroscience Institute
Louisville, Kentucky, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
November 4, 2024
Primary Completion Date
June 1, 2034
Completion Date
June 1, 2034
Last Updated
February 17, 2026
680
ESTIMATED participants
efgartigimod
BIOLOGICAL
Lead Sponsor
argenx
NCT07247279
NCT07246564
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07470151